SaRI 59-801
- CAS No.
- 80565-58-8
- Chemical Name:
- SaRI 59-801
- Synonyms
- SaRI 59-801;N,N-DIMETHYL-2-(3-ETHYL-5-METHYL-4-ISOXAZOLYL)-BETA-HYDROXYTRYPTAMINE;2-(dimethylamino)-1-[2-(3-ethyl-5-methyl-1,2-oxazol-4-yl)-1H-indol-3-yl]ethanol;1H-Indole-3-methanol, α-[(dimethylamino)methyl]-2-(3-ethyl-5-methyl-4-isoxazolyl)-;hypoglycemic,oral,Sari 59 801,blood glucose,SaRI 59-801,plasma insulin,Sari 59801,Inhibitor,inhibit
- CBNumber:
- CB91400327
- Molecular Formula:
- C18H23N3O2
- Molecular Weight:
- 313.39
- MDL Number:
- MFCD00159831
- MOL File:
- 80565-58-8.mol
Last updated:2023-09-20 16:43:00
| FDA UNII | S1S4AKI7QY |
|---|
SAFETY
Risk and Safety Statements
| Symbol(GHS) |  GHS06 |
|---|---|
| Signal word | Danger |
| Hazard statements | H319-H301-H335-H315 |
| Precautionary statements | P264-P280-P302+P352-P321-P332+P313-P362-P264-P270-P301+P310-P321-P330-P405-P501-P264-P280-P305+P351+P338-P337+P313P |
SaRI 59-801 price More Price(4)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich | S879754 | N,N-DIMETHYL-2-(3-ETHYL-5-METHYL-4-ISOXAZOLYL)-BETA-HYDROXYTRYPTAMINE Aldrich | 80565-58-8 | 50mg | $29.8 | 2024-03-01 | Buy |
| American Custom Chemicals Corporation | CHM0162306 | 2-(DIMETHYLAMINO)-1-[2-(3-ETHYL-5-METHYL-1,2-OXAZOL-4-YL)-1H-INDOL-3-YL]ETHAN-1-OL 95.00% | 80565-58-8 | 1G | $621.69 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | CHM0162306 | 2-(DIMETHYLAMINO)-1-[2-(3-ETHYL-5-METHYL-1,2-OXAZOL-4-YL)-1H-INDOL-3-YL]ETHAN-1-OL 95.00% | 80565-58-8 | 5G | $838.12 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | CHM0162306 | 2-(DIMETHYLAMINO)-1-[2-(3-ETHYL-5-METHYL-1,2-OXAZOL-4-YL)-1H-INDOL-3-YL]ETHAN-1-OL 95.00% | 80565-58-8 | 10G | $1183.57 | 2021-12-16 | Buy |
SaRI 59-801 Preparation Products And Raw materials
Raw materials
Preparation Products
SaRI 59-801 Suppliers
Global( 8)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Nantong HI-FUTURE Biology Co., Ltd. | +undefined18051384581 | sales@chemhifuture.com | China | 3136 | 58 |
| TargetMol Chemicals Inc. | +1-781-999-5354 | support@targetmol.com | United States | 19973 | 58 |
| Changzhou Furuisi Biotechnology Co., Ltd | 0519-85524369 | 3477467573@qq.com | China | 8618 | 58 |
| Nantong Hi-Future Biotechnology Co., Ltd | 18051384581 | sales@chemhifuture.com | China | 3059 | 58 |
| InvivoChem | 13549236410 | sales@invivochem.cn | China | 6749 | 58 |
| TargetMol Chemicals Inc. | 4008200310 | marketing@tsbiochem.com | China | 24017 | 58 |
| Shanghai Tachizaki Biomedical Research Center | 18014399201 | sales@chemlab-tachizaki.com | China | 2497 | 58 |
N,N-DIMETHYL-2-(3-ETHYL-5-METHYL-4-ISOXAZOLYL)-BETA-HYDROXYTRYPTAMINE
SaRI 59-801
2-(dimethylamino)-1-[2-(3-ethyl-5-methyl-1,2-oxazol-4-yl)-1H-indol-3-yl]ethanol
1H-Indole-3-methanol, α-[(dimethylamino)methyl]-2-(3-ethyl-5-methyl-4-isoxazolyl)-
hypoglycemic,oral,Sari 59 801,blood glucose,SaRI 59-801,plasma insulin,Sari 59801,Inhibitor,inhibit
80565-58-8